Why does quick‐release bromocriptine decrease cardiac events?
DSH Bell - Diabetes, Obesity and Metabolism, 2011 - Wiley Online Library
A placebo‐controlled prospective safety study of quick‐release bromocriptine in patients
with type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible …
with type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible …
Why does quick-release bromocriptine decrease cardiac events?
DSH Bell - Diabetes, obesity & metabolism, 2011 - pubmed.ncbi.nlm.nih.gov
A placebo-controlled prospective safety study of quick-release bromocriptine in patients with
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …
Why does quick-release bromocriptine decrease cardiac events?
DS Bell - Diabetes, Obesity & Metabolism, 2011 - europepmc.org
A placebo-controlled prospective safety study of quick-release bromocriptine in patients with
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …
Why does quick‐release bromocriptine decrease cardiac events?
DSH Bell - Diabetes, Obesity and Metabolism, 2011 - infona.pl
A placebo‐controlled prospective safety study of quick‐release bromocriptine in patients
with type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible …
with type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible …
Why does quick-release bromocriptine decrease cardiac events?
DSH Bell - Diabetes, Obesity & Metabolism, 2011 - search.ebscohost.com
A placebo-controlled prospective safety study of quick-release bromocriptine in patients with
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …
type 2 diabetes has shown a 40% reduction in cardiovascular events. Possible explanations …